New Study Demonstrates Burdensome Cost of Blood Cancer Care Read more about New Study Demonstrates Burdensome Cost of Blood Cancer Care
LLS Applauds Significant Approval for Leukemia Patients Read more about LLS Applauds Significant Approval for Leukemia Patients
FDA Approval of AML Therapy is a Significant Advance for Blood Cancer Patients Read more about FDA Approval of AML Therapy is a Significant Advance for Blood Cancer Patients
LLS Investment Pays Off: FDA Approves Immunotherapy for Blood Cancer Patients Read more about LLS Investment Pays Off: FDA Approves Immunotherapy for Blood Cancer Patients
FDA Approval: LLS Applauds New Advance for Acute Lymphoblastic Leukemia Read more about FDA Approval: LLS Applauds New Advance for Acute Lymphoblastic Leukemia
The Leukemia & Lymphoma Society Applauds Therapy Advances for Myeloma Patients Read more about The Leukemia & Lymphoma Society Applauds Therapy Advances for Myeloma Patients
The Leukemia & Lymphoma Society Applauds FDA's Approval of Ibrutinib for Certain Patients with Mantle Cell Lymphoma Read more about The Leukemia & Lymphoma Society Applauds FDA's Approval of Ibrutinib for Certain Patients with Mantle Cell Lymphoma
The Leukemia & Lymphoma Society Applauds FDA's Approval of Ibrutinib for Patients with Waldenstrom's Macroglobulinemia Read more about The Leukemia & Lymphoma Society Applauds FDA's Approval of Ibrutinib for Patients with Waldenstrom's Macroglobulinemia
The Leukemia & Lymphoma Society Applauds FDA's Approval of Idelalisib To Treat Three Types of Blood Cancers Read more about The Leukemia & Lymphoma Society Applauds FDA's Approval of Idelalisib To Treat Three Types of Blood Cancers